Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2006 1
2009 1
2010 2
2012 4
2013 3
2014 2
2015 10
2016 7
2017 5
2018 11
2019 11
2020 11
2021 18
2022 20
2023 25
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group. Electronic address:; RECOVERY Collaborative Group. RECOVERY Collaborative Group. Electronic address:, et al. Lancet. 2023 May 6;401(10387):1499-1507. doi: 10.1016/S0140-6736(23)00510-X. Epub 2023 Apr 13. Lancet. 2023. PMID: 37060915 Free PMC article. Clinical Trial.
PROTACs: Promising approach for anticancer therapy.
Kaur SD, Bedi N, Kumar D, Kapoor DN. Kaur SD, et al. Cancer Lett. 2023 Mar 1;556:216065. doi: 10.1016/j.canlet.2023.216065. Epub 2023 Jan 13. Cancer Lett. 2023. PMID: 36642326 Review.
COVID and Kidney: The Struggle So Far.
Kaur S, Mehta S. Kaur S, et al. Int J Appl Basic Med Res. 2023 Jan-Mar;13(1):1-4. doi: 10.4103/ijabmr.ijabmr_571_22. Epub 2023 Mar 27. Int J Appl Basic Med Res. 2023. PMID: 37266530 Free PMC article. No abstract available.
DNA methylation episignatures are sensitive and specific biomarkers for detection of patients with KAT6A/KAT6B variants.
Vos N, Reilly J, Elting MW, Campeau PM, Coman D, Stark Z, Tan TY, Amor DJ, Kaur S, StJohn M, Morgan AT, Kamien BA, Patel C, Tedder ML, Merla G, Prontera P, Castori M, Muru K, Collins F, Christodoulou J, Smith J, Zeev BB, Murgia A, Leonardi E, Esber N, Martinez-Monseny A, Casas-Alba D, Wallis M, Mannens M, Levy MA, Relator R, Alders M, Sadikovic B. Vos N, et al. Among authors: kaur s. Epigenomics. 2023 Mar;15(6):351-367. doi: 10.2217/epi-2023-0079. Epub 2023 May 30. Epigenomics. 2023. PMID: 37249002
Role of Cannabinoids in Various Diseases: A Review.
Kaur S, Sharma N, Roy A. Kaur S, et al. Curr Pharm Biotechnol. 2022;23(11):1346-1358. doi: 10.2174/1389201023666211223164656. Curr Pharm Biotechnol. 2022. PMID: 34951355 Review.
COVID-19 Vaccine: A comprehensive status report.
Kaur SP, Gupta V. Kaur SP, et al. Virus Res. 2020 Oct 15;288:198114. doi: 10.1016/j.virusres.2020.198114. Epub 2020 Aug 13. Virus Res. 2020. PMID: 32800805 Free PMC article. Review.
Applications of CRISPR as a potential therapeutic.
Luthra R, Kaur S, Bhandari K. Luthra R, et al. Among authors: kaur s. Life Sci. 2021 Nov 1;284:119908. doi: 10.1016/j.lfs.2021.119908. Epub 2021 Aug 25. Life Sci. 2021. PMID: 34453943 Review.
PPARγ-targeting Potential for Radioprotection.
Kaur S, Nag A, Singh AK, Sharma K. Kaur S, et al. Curr Drug Targets. 2018;19(15):1818-1830. doi: 10.2174/1389450119666180131105158. Curr Drug Targets. 2018. PMID: 29384061 Review.
128 results